XPOF vs BFAM vs HIMS vs LRN

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -1. 7% for Xponential Fitness, Inc. (XPOF). Stride, Inc. (LRN) offers the better valuation at 15. 4x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Xponential Fitness, Inc. (XPOF) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Stride, Inc.

(LRN) is the cheapest at 15. 4x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Xponential Fitness, Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stride, Inc. wins at 0. 22x versus Bright Horizons Family Solutions Inc. 's 0. 27x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Stride, Inc.

(LRN) delivered a total return of +223. 1%, compared to -49. 8% for Bright Horizons Family Solutions Inc. (BFAM). Over 10 years, the gap is even starker: LRN returned +666. 0% versus XPOF's -46. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Bright Horizons Family Solutions Inc.

(BFAM) is the lower-risk stock at 0. 27β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 799% more volatile than BFAM relative to the S&P 500. On balance sheet safety, Stride, Inc. (LRN) carries a lower debt/equity ratio of 37% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -1. 7% for Xponential Fitness, Inc. (XPOF). On earnings-per-share growth, the picture is similar: Bright Horizons Family Solutions Inc. grew EPS 40. 0% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Stride, Inc.

(LRN) is the more profitable company, earning 12. 0% net margin versus -10. 7% for Xponential Fitness, Inc. — meaning it keeps 12. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XPOF leads at 25. 3% versus 5. 2% for HIMS. At the gross margin level — before operating expenses — XPOF leads at 75. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Stride, Inc. (LRN) is the more undervalued stock at a PEG of 0. 22x versus Bright Horizons Family Solutions Inc. 's 0. 27x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Xponential Fitness, Inc. (XPOF) trades at 10. 9x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 40. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BFAM: 39. 9% to $95. 57.

In this comparison, XPOF (2.

5% yield) pays a dividend. BFAM, HIMS, LRN do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Stride, Inc.

(LRN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 46), +666. 0% 10Y return). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LRN: +666. 0%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (XPOF (Consumer Cyclical) and BFAM (Consumer Cyclical) and HIMS (Healthcare) and LRN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: XPOF is a small-cap quality compounder stock; BFAM is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; LRN is a small-cap high-growth stock. XPOF pays a dividend while BFAM, HIMS, LRN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.